tirofiban has been researched along with Inflammation in 10 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 6 (60.00) | 29.6817 |
| 2010's | 3 (30.00) | 24.3611 |
| 2020's | 1 (10.00) | 2.80 |
| Authors | Studies |
|---|---|
| Deng, L; Jia, HZ; Li, MC; Zhu, W | 1 |
| Dash, S; Kar, D; Ray, M; Sahrawat, TR; Shahbazi, S; Singh, S | 1 |
| Akima, S; Blyth, K; Chapman, JR; Favaloro, E; Hawthorne, WJ; Mudaliar, Y; O'Connell, PJ; Patel, A | 1 |
| Aboujaoudé, S; Azar, RR; Badaoui, G; Barakett, V; Germanos, M; Hamdan, R; Kassab, R; Salamé, E; Sarkis, A | 1 |
| Aroney, CN; Bett, JH; Perrin, EJ; Ray, MJ; Walters, DL; Wood, P | 1 |
| Bonz, AW; Ertl, G; Held, S; Jacobs, M; Lengenfelder, B; Strotmann, J; Voelker, W | 1 |
| Baris, N; Duman, C; Ercan, E; Onbasili, OA; Tengiz, I | 1 |
| Coull, BM; McDonagh, PF; Ritter, LS; Stempel, KM | 1 |
| Baum, H; Braun, S; Dibra, A; Dirschinger, J; Hadamitzky, M; Kastrati, A; Mehilli, J; Schömig, A; Schühlen, H | 1 |
| Azcona, L; Farré, J; Fernández-Ortiz, A; López-Farré, AJ; Macaya, C; Romero, J; Sacristán, D; Zamorano-León, JJ | 1 |
5 trial(s) available for tirofiban and Inflammation
| Article | Year |
|---|---|
Effect of high bolus dose tirofiban on the inflammatory response following percutaneous coronary intervention.
Topics: Angioplasty, Balloon, Coronary; Biomarkers; C-Reactive Protein; CD40 Antigens; Clopidogrel; Creatine Kinase, MB Form; Female; Humans; Inflammation; Interleukin-6; Male; Middle Aged; Platelet Aggregation; Platelet Aggregation Inhibitors; Prospective Studies; Ticlopidine; Time Factors; Tirofiban; Tyrosine | 2010 |
High-dose tirofiban with enoxaparin and inflammatory markers in high-risk percutaneous intervention.
Topics: Acute Coronary Syndrome; Aged; Angioplasty, Balloon; Anticoagulants; Biomarkers; Blood Coagulation Factors; Blood Platelets; CD40 Ligand; Enoxaparin; Female; Flow Cytometry; Heparin; Humans; Inflammation; Male; Middle Aged; Platelet Activation; Platelet Aggregation Inhibitors; Prospective Studies; Tirofiban; Tyrosine | 2010 |
Cytokine response after percutaneous coronary intervention in stable angina: effect of selective glycoprotein IIb/IIIa receptor antagonism.
Topics: Angina Pectoris; Angioplasty, Balloon, Coronary; C-Reactive Protein; Coronary Disease; Cytokines; Double-Blind Method; Humans; Inflammation; Interleukin-1; Interleukin-6; Platelet Glycoprotein GPIIb-IIIa Complex; Prospective Studies; Tirofiban; Troponin; Tumor Necrosis Factor-alpha; Tyrosine | 2003 |
Effect of tirofiban on C-reactive protein in non-ST-elevation myocardial infarction.
Topics: Analysis of Variance; C-Reactive Protein; Female; Heparin; Humans; Inflammation; Male; Middle Aged; Myocardial Infarction; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Prospective Studies; Tirofiban; Tyrosine | 2004 |
Effects of coronary prestenting platelet inhibition on coronary poststenting inflammation.
Topics: Aged; alpha 1-Antitrypsin; Clopidogrel; Drug Administration Schedule; Female; Humans; Inflammation; Infusions, Intravenous; Male; Myocardial Infarction; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Stents; Ticlopidine; Time Factors; Tirofiban; Tyrosine | 2008 |
5 other study(ies) available for tirofiban and Inflammation
| Article | Year |
|---|---|
Comparison of the effect of ticagrelor combined with tirofiban versus clopidogrel combined with tirofiban on inflammation response and prognosis of patients with unstable angina pectoris in long term follow-up.
Topics: Aged; Angina, Unstable; Biomarkers; C-Reactive Protein; Clopidogrel; Drug Administration Schedule; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Inflammation; Interleukin-1beta; Interleukin-6; Kaplan-Meier Estimate; Male; Matrix Metalloproteinase 9; Middle Aged; Platelet Aggregation Inhibitors; Prognosis; Prospective Studies; Ticagrelor; Tirofiban; Tumor Necrosis Factor-alpha | 2021 |
Drug Targets for Cardiovascular-Safe Anti-Inflammatory: In Silico Rational Drug Studies.
Topics: Anti-Inflammatory Agents; Aspirin; Binding Sites; Caffeic Acids; Celecoxib; Coumaric Acids; Cyclooxygenase 1; Cyclooxygenase 2; ERG1 Potassium Channel; Eugenol; Heart; Humans; Inflammation; Integrin alpha2; Protein Structure, Tertiary; Tirofiban; Tyrosine | 2016 |
Tirofiban and activated protein C synergistically inhibit the Instant Blood Mediated Inflammatory Reaction (IBMIR) from allogeneic islet cells exposure to human blood.
Topics: ABO Blood-Group System; Blood Coagulation; Dose-Response Relationship, Drug; Drug Synergism; Humans; In Vitro Techniques; Inflammation; Islets of Langerhans Transplantation; Lymphocytes; Perfusion; Platelet Aggregation Inhibitors; Protein C; Recombinant Proteins; Tirofiban; Transplantation, Homologous; Tyrosine | 2009 |
Leukocyte-platelet aggregates in rat peripheral blood after ischemic stroke and reperfusion.
Topics: Analysis of Variance; Animals; Anticoagulants; Biomarkers; Blood Platelets; Brain Ischemia; Disease Models, Animal; Flow Cytometry; Inflammation; Leukocytes; Male; Myocardial Reperfusion Injury; Neutrophil Activation; Neutrophils; Platelet Aggregation; Platelet Aggregation Inhibitors; Polysaccharides; Rats; Rats, Sprague-Dawley; Reactive Oxygen Species; Severity of Illness Index; Stroke; Time Factors; Tirofiban; Tyrosine | 2005 |
Inflammatory response after intervention assessed by serial C-reactive protein measurements correlates with restenosis in patients treated with coronary stenting.
Topics: Abciximab; Aged; Angina Pectoris; Angina, Unstable; Angioplasty, Balloon, Coronary; Antibodies, Monoclonal; Anticoagulants; Aspirin; Biomarkers; C-Reactive Protein; Clopidogrel; Coronary Angiography; Coronary Restenosis; Coronary Stenosis; Female; Heparin; Humans; Immunoglobulin Fab Fragments; Inflammation; Male; Middle Aged; Postoperative Period; Premedication; Stents; Ticlopidine; Tirofiban; Tyrosine | 2005 |